FDA Considers Range of Measures to Enhance Safety of High-Risk Excipients
This article was originally published in The Gold Sheet
Executive Summary
FDA eyes all high-risk excipients in response to DEG-tainted glycerin issue.
You may also be interested in...
Biden Launches Effort To Strengthen US Pharmaceutical Supply Chain
A fresh executive order from US president Joe Biden calls for short-term and long-term study, broad consultation, and co-ordination with allies on the domestic supply chain.
Biden Launches Effort To Strengthen US Pharmaceutical Supply Chain
Executive order calls for short-term and long-term study, broad consultation, coordination with allies.
How US FDA Will Unleash Attack On COVID-19 Variants Once Global Consensus Is Reached
Agency outlines plans to authorize variant COVID-19 vaccines and therapeutics based on swift quality assessments.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: